The effect of tofacitinib on residual pain in patients with psoriatic arthritis by Dougados, M, van der Heijde, D, Bingham, CO, Taylor, PC, Fallon, L, Woolcott, J, Brault, Y, Wang, L, Kessouri, M

Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation by Taylor, P, Mease, P, Bushmakin, A, Cappelleri, J, Fleischmann, R, Fallon, L, Woolcott, J, Ogdie, A, Azevedo, V, De Vlam, K

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib by de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib by de Vlam, K, Ogdie, A, Bushmakin, A, Cappelleri, J, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J, Mease, P

Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis by de Vlam, K, Mease, PJ, Bushmakin, AG, Fleischmann, R, Ogdie, A, Azevedo, VF, Merola, JF, Woolcott, J, Cappelleri, JC, Fallon, L, Taylor, PC

Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis by Ogdie, A, de Vlam, K, Bushmakin, A, Cappelleri, J, Mease, P, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J

Treatment modes in rheumatoid arthritis: factors influencing patient preference by Taylor, P, Betteridge, N, Brown, T, Woolcott, J, Kivitz, A, Zerbini, C, Whalley, D, Olayinka-Amao, O, Chen, C, Dahl, P, Ponce de Leon, D, Gruben, D, Fallon, L

Treatment mode preferences in rheumatoid arthritis: moving toward shared decision-making by Taylor, PC, Betteridge, N, Brown, T, Woolcott, J, Kivitz, A, Zerbini, C, Whalley, D, Olayinka-Amao, O, Chen, C, Dahl, P, Ponce De Leon, D, Gruben, D, Fallon, L

Pain reduction in patients with rheumatoid arthritis receiving tofacitinib monotherapy with or without pain medication: A post hoc analysis of pooled data from phase 2, phase 3 an... by Taylor, PC, van De Laar, M, Curtis, JR, Azevedo, VF, Rivas, JL, Dahl, P, Wang, L, Iikuni, N, Shi, H, Woolcott, J, Benkhalifa, S, Gomez-Reino, JJ, Dougados, M

Treatment modes in rheumatoid arthritis: Moving toward shared decision-making by Taylor, P, Betteridge, N, Brown, T, Woolcott, J, Kivitz, A, Zerbini, C, Whalley, D, Olayinka-Amao, O, Chen, C, Dahl, P, Ponce de Leon, D, Gruben, D, Fallon, L

Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making by Taylor PC, Betteridge N, Brown TM, Woolcott J, Kivitz AJ, Zerbini C, Whalley D, Olayinka-Amao O, Chen C, Dahl P, Ponce de Leon D, Gruben D, Fallon L

Get full text